Akira Endo: Father of Statins.

Cureus

Internal Medicine, West Virginia University School of Medicine, Parkersburg, USA.

Published: August 2024

There was an unprecedented increase in cardiovascular mortality during the 20th century, which ultimately led to a deeper understanding of cholesterol and its role in cardiovascular disease. Akira Endo is a medical innovator who sought to change the tide of this epidemic. He is often referred to as the "Father of Statins" because of his identification of the first 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) inhibitor, which fostered a new era in cholesterol treatment. The offspring of this discovery - statin medications - changed the landscape of cardiovascular prevention and improved outcomes for millions of patients across the globe. Arika Endo used his prior research experience in biochemistry and fungi to create a new way to meet the objective of reducing cardiovascular morbidity and mortality. In this way, he should be recognized not only for this discovery of statins but as a role model for researchers at any stage of their careers.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11439472PMC
http://dx.doi.org/10.7759/cureus.68198DOI Listing

Publication Analysis

Top Keywords

akira endo
8
endo father
4
father statins
4
statins unprecedented
4
unprecedented increase
4
cardiovascular
4
increase cardiovascular
4
cardiovascular mortality
4
mortality 20th
4
20th century
4

Similar Publications

The novel mpox clade Ib initially identified in the Domestic Republic of Congo has spread to its multiple neighbouring countries as well as countries beyond the African continent. We characterised the global risk of importation of mpox clade Ib, highlighting the need to ramp up surveillance capacity for early detection.

View Article and Find Full Text PDF
Article Synopsis
  • Extracorporeal membrane oxygenation (ECMO) offers temporary support for patients with severe trauma, and this study examines the outcomes of patients treated with veno-arterial ECMO (V-A ECMO) in Japan between 2019 and 2021.
  • Out of 72,439 severe trauma patients, only 51 received V-A ECMO, with a discharge survival rate of 31.3%.
  • The findings suggest that V-A ECMO may be beneficial in severe trauma cases, particularly where traditional interventions aren't effective, but further research is needed to clarify its indications.
View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to evaluate a new technique for treating dialysis access stenosis where blockages occur on both the anastomotic and central venous sides, using a single sheath for bidirectional percutaneous transluminal angioplasty (PTA).
  • - Involving 20 patients with 26 cases, the procedures were performed in an outpatient setting, utilizing a vertical puncture approach. Sheath inversion was successfully completed in all cases, which simplified the process by eliminating the need for additional sheath placements.
  • - Results showed successful PTA in all cases without major complications, with data collected on vessel diameter, sheath inversion success, and primary patency rates up to one year, indicating the effectiveness and safety of this technique.
View Article and Find Full Text PDF

'Not finding causal effect' is not 'finding no causal effect' of school closure on COVID-19.

F1000Res

September 2024

The Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK.

In a paper recently published in , Fukumoto et al. tried to assess the government-led school closure policy during the early phase of the COVID-19 pandemic in Japan. They compared the reported incidence rates between municipalities that had and had not implemented school closure in selected periods from March-May 2020, where they matched for various potential confounders, and claimed that there was no causal effect on the incidence rates of COVID-19.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!